Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Thomas Jefferson University
Penn State University
Gamida Cell ltd
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Hutchmed
M.D. Anderson Cancer Center
Brown University
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
CRISPR Therapeutics
Incyte Corporation
Children's Oncology Group
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Scripps Translational Science Institute
Washington University School of Medicine
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Thomas Jefferson University
Eli Lilly and Company
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Takeda
BeiGene
GlaxoSmithKline